A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Procalcitonin
MessageProcalcitonin levels below 0.50 ng/mL do not exclude an infection, because localized infections (without systemic signs) may also be associated with such low levels.
Test Code
831
Preferred Specimen
One 4 mL plasma separator tube or serum separator tube..
Minimum Volume
2 mL serum or plasma at 2-8°C. (Min: 0.3 mL) Submit in ARUP Standard Transport Tube. Submit specimen according to Biological Substance, Category B, shipping guidelines.
Transport Temperature
2 mL serum or plasma at 2-8°C. (Min: 0.3 mL) Submit in ARUP Standard Transport Tube. Submit specimen according to Biological Substance, Category B, shipping guidelines.
Specimen Stability
After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 1 month
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Specimens collected in citrate anticoagulant.
Methodology
Immunofluorescent
Setup Schedule
Sun-Sat
Report Available
Within 24 hours
Limitations
Remove serum or plasma from cells ASAP. The same specimen type (serum, plasma) should be used throughout the patient's clinical course. Serum separater tubes or plain red tubes need to sit for 15-20 minutes for proper clot formation and to ensure the absence of fibrin in the serum which can interfere with this assay.
Clinical Significance
Procalcitonin > 2.00 ng/mL:Procalcitonin levels above 2.00 ng/mL on the first day of ICU admission represent a high risk for progression to severe sepsis and/or septic shock.Procalcitonin < 0.50 ng/mL:Procalcitonin levels below 0.50 ng/mL on the first day of ICU admission represent a low risk for progression to severe sepsis and/or septic shock.If the procalcitonin measurement is performed shortly after the systemic infection process has started (usually less than 6 hours), these values may still be low. As various non-infectious conditions are known to induce procalcitonin as well, procalcitonin levels between 0.50 ng/mL and 2.00 ng/mL should be reviewed carefully to take into account the specific clinical background and condition(s) of the individual patient.